Drug discontinuation: Lamivudine Tablet
FDA lists 2 presentations as To Be Discontinued. Companies: ViiV Healthcare Company.
- Published by source
- 2026-10-19
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-22
Affected
- Manufacturer
- ViiV Healthcare Company
- Products
- Lamivudine Tablet
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: To Be Discontinued
Remedy / actions:
- The anticipated date that ViiV will cease distribution of the products is approximately April 15, 2027; Discontinuation of the manufacture of the drug
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2026-10-19
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #1060 | new | 2026-10-22 | 26b5d4d6525d…ffa752 | 8efec0510fbd…bc2ec0 |
Chain head: #1076 8ad5adc30b9b…88ce20